Shuttle Pharmaceuticals issues 3,737,482 shares in unregistered sale after preferred conversions
SHPH•Unregistered sale exemption
The transaction relied on the Securities Act Section 4(a)(2) exemption for unregistered sales.
Warrants and pre-funded warrants also issued
Separately issued warrants as of Sept. 9, 2026, covering about 927,114 shares at an exercise price of $10.3.
The company also issued pre-funded warrants covering about 16,932,508 shares.
Common shares issued after preferred conversions
Shuttle Pharmaceuticals issued 3,737,482 common shares via conversions of Series B-1 and Series B-2 preferred stock as of Sept. 14, 2026.
